• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Alzheimer's disease

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Senate bill aims to keep NIH, CDC funds intact

The draft legislation would also keep NIH’s 27 institutes and centers, in opposition to Trump’s consolidation plans.
Gabrielle Masson Aug 4, 2025 11:30am
Brain wrapped in cash money

MapLight raises $373M to plot phase 2 journey for Cobenfy rival

Jul 28, 2025 10:23am
blood test tube

Roche nets EU approval for blood test to rule out Alzheimer's

Jul 25, 2025 11:00am
colorful brain art model

Acumen taps JCR’s brain barrier tech for $555M Alzheimer’s deal

Jul 15, 2025 8:01am
blood test tube

Quest to carry Fujirebio’s FDA-cleared Alzheimer’s blood test

Jul 11, 2025 11:40am
failure crash no fail rocket cancelled end

INmune flunks Alzheimer’s trial, focuses on subgroup efficacy

Jun 30, 2025 8:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings